Key Takeaways Novo Nordisk shares soared Tuesday after the company said the Food and Drug Administration approved an oral version of its popular Wegovy weight-loss drug.The Danish drugmaker said it hopes to launch the pill in the U.S. in early January. Could a new weight-loss pill be just what Novo Nordisk (NVO) needs to revive its stock? U.S.-listed shares of the Danish drugmaker surged 9% in recent trading after the company said it received Food and Drug Administration approval for an oral version of ...